The UCI has handed out four-year doping bans to two riders from the Iranian women’s track team.
Both riders tested positive at the 2018 Asian Track Championships in Malaysia, but have only been sanctioned this week.
>> Struggling to get to the shops? Try 6 issues of Cycling Weekly magazine for just £6 delivered to your door <<
Maedeh Nazari and Fatemeh Hadavand had anabolic steroids in their system during the track competition, which resulted in the UCI handing out bans two years later.
Nazari, 21, and Hadavand 22, have both been banned for four years, with their suspension back-dated to the date the anti-doping rule violations were committed, which means they will be eligible to race again in 2022.
Hadavand won the junior national championships back in 2015, winning both the time trial and the road race in the same year.
She went on to finish third in the elite nationals the following year.
Nazari has also claimed medals in Iran’s national championships, taking second in the time trial and third in the road race in 2016.
Both riders have also claimed national titles on the track.
The riders were tested two days apart on February 2018 at the Asian Track Champs at the Velodrom Nasional in Nilai, Malaysia.
International governing body the UCI has not released a statement regarding the bans, but the two riders were added to the list of riders ineligible to race due to doping.
The last rider banned by the UCI was Jarlinson Pantano, who had already retired from the sport in the wake of his positive doping test.
The Colombian pro, who last rode for Trek-Segafredo, was initially suspended and fired from his team in 2019 after he returned a positive test for the blood booster EPO.
Pantano then announced his retirement from the sport, saying he didn’t see the point in spending his money on fighting the UCI.
Then in May, the UCI announced the 31-year-old had been suspended from the sport for four years.